Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (1486)	12/16/2008 8:45:32 PM
From: JMarcus	Read Replies (1) \| Respond to of 1494

The stock sure took a beating on today's news, but the volume wasn't large enough to make it very meaningful. My guess: a few folks had just climbed on-board hoping for a short-term bounce on the Xerecept news, which Paul Freiman predicted at the stockholders meeting. Once the news was out, they didn't care to stick around and so bailed. I don't think the Xerecept news was disappointing. It is just that the market (other than the holders of the 80,000 shares that sold today -- which was about the same number that traded yesterday too) doesn't ascribe any value to Xerecept. The folks hoping to profit on the Xerecept news misjudged the market and then bailed in disappointment. Anyone else have a different take on today's action? Marc